Clinical trial
An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation (GENPET)
NCT05097274 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation (GENPET)
- Lead sponsor
- Institute of Cancer Research, United Kingdom
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 15, 2015
- Completion date
- December 31, 2032
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atm gene mutation, brca mutation, chek2 gene mutation, hoxb13 germline mutation, mismatch repair gene mutation, palb2 gene mutation, prostate cancer